K&L Gates advises healthcare and biotech clients on regulatory, transactional, and commercial matters across the product lifecycle, from R&D through to commercialization and cross-border transactions, headed by Andrew Ruskin in Washington, DC and Michael Hinckle in North Carolina.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • Seamless interaction. Understands the problem as if it were their own and presents the solution in a practical way that is clear and easy to apply.
  • The team is both professional and personable -- they have great partners and make you feel like you're their only client.
  • K&L Gates is acting as lead counsel in a mid-market deal within the Life Sciences and Medical Devices industry. The transaction spans 11 jurisdictions, including the US, EU, China, and East Asia. I have worked with K&L Gates NY, especially Mr. Whitney Smith on many cross-border or international elements. Mr. Smith and his team have provided me with responsive legal advice and representation on various matters involving mergers, acquisitions, divestitures, joint ventures, private equity transactions, corporate governance, dissolutions, commercial and government contracts, government relations, corporate reorganizations, labor and employment, intellectual property, environmental, health and safety compliance, trade compliance, antitrust compliance and litigation, bankruptcy, and other general corporate and regulatory matters.
  • The firm's regulatory counsel Michael Hinckle was knowledgeable, professional, and responsive in the Life Sciences space. Meanwhile, the Corporate team led by NY Partner Mr. Whitney Smith effectively navigated the global regulatory landscape and operational challenges, coordinated tax issues, and pivoted to practical solutions that enabled the successful closing of a complex transaction.

Key clients

  • Novozymes North America
  • Visterra, Inc.
  • Novartis
  • Rona Therapeutics
  • Abpro
  • Arbor Biotechnologies, Inc.
  • Flagship Pioneering, Inc.
  • Gilead
  • Sanofi Aventis

Lawyers

Firms to watch

Practice head

Andrew Ruskin; Michael Hinckle